Paper · 35902802
Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage.
Li J and 9 others. Cell Mol Biol Lett, 2022. Cited by 96 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage. Papers, record 35902802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35902802
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artemisinins | Major topic |
| Cartilage, Articular | Major topic |
| Osteoarthritis | Major topic |
| Animals | |
| Autophagy | |
| Chondrocytes | |
| Interleukin-1beta | |
| Phosphatidylinositol 3-Kinases | |
| Proto-Oncogene Proteins c-akt | |
| RANK Ligand | |
| Rats | |
| Signal Transduction | |
| TOR Serine-Threonine Kinases |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CJ20210104 | Changzhou Sci&Tech Program | PubMed | ||
| CZQM2020059 | Young Talent Development Plan of Changzhou Health Commission | PubMed | ||
| 2020KY313 | Zhejiang Medicine and Health Technology Plan | PubMed | ||
| 2020AY30020 | Jiaxing Science and Technology Project | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,539,107 | Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors. | Bone | 2008 | https://conductscience.org/library/papers/18539107 | PubMed |
| 2 | 30,453,055 | Osteoarthritis year in review 2018: clinical. | Osteoarthritis Cartilage | 2019 | https://conductscience.org/library/papers/30453055 | PubMed |
| 3 | 21,205,641 | Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. | Science | 2011 | https://conductscience.org/library/papers/21205641 | PubMed |
| 4 | 28,294,321 | Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo. | J Cell Physiol | 2018 | https://conductscience.org/library/papers/28294321 | PubMed |
| 5 | 33,613,618 | The Efficacy and Safety of the mTOR Signaling Pathway Activator, MHY1485, for in vitro Activation of Human Ovarian Tissue. | Front Genet | 2020 | https://conductscience.org/library/papers/33613618 | PubMed |
| 6 | 31,546,898 | Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31546898 | PubMed |
| 7 | 22,210,913 | RANKL induces organized lymph node growth by stromal cell proliferation. | J Immunol | 2012 | https://conductscience.org/library/papers/22210913 | PubMed |
| 8 | 32,266,056 | Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. | Cell Biosci | 2020 | https://conductscience.org/library/papers/32266056 | PubMed |
| 9 | 31,126,594 | An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). | Semin Arthritis Rheum | 2019 | https://conductscience.org/library/papers/31126594 | PubMed |
| 10 | 21,931,183 | Hormesis, cell death and aging. | Aging (Albany NY) | 2011 | https://conductscience.org/library/papers/21931183 | PubMed |
1 to 10 of 51
See all 51 referencesCited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,839,683 | A serum proteomics-based predictive model for steroid-resistant immune checkpoint inhibitor associated myocarditis. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42839683 | PubMed |
| 42,687,185 | ROS-responsive injectable hydrogel enables controlled release of human adipose tissue-derived extracellular vesicles for multifaceted osteoarthritis therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42687185 | PubMed |
| 42,577,500 | New therapeutic target for osteoarthritis: modulating immune-metabolic aberrations and micromilieu remodeling in underlying bone. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42577500 | PubMed |
| 42,440,180 | A Combination of Artemisinin, N-acetylcysteine, Resveratrol, and Hesperidin Ameliorates Hippocampal Damage and Pathological Features in an Experimental Model of Alzheimer's Disease. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42440180 | PubMed |
| 42,437,187 | Astragaloside IV Alleviates Osteoarthritis by Upregulating ETS2: A Bioinformatics and Experimental Study. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42437187 | PubMed |
| 42,424,009 | TRIM65 accelerates VSMC-derived foam cell formation and arteriosclerosis progression by inhibiting mitophagy. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42424009 | PubMed |
| 42,287,035 | Integrative Multiomics and Network Pharmacology Exploration of Active Components and Mechanisms of Action of Qufu Shengxin Ointment in Treating Chronic Nonhealing Wounds. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42287035 | PubMed |
| 42,245,479 | Traditional Chinese medicine-derived monomers delay osteoarthritis progression by regulating mitochondrial homeostasis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42245479 | PubMed |
| 42,220,285 | Research progress on cellular senescence in the pathogenesis and treatment of osteoarthritis and temporomandibular joint osteoarthritis. | J Oral Facial Pain Headache | 2026 | https://conductscience.org/library/papers/42220285 | PubMed |
| 42,145,974 | Modulation of Neuronal Mitochondrial Injury by Gualou Guizhi Decoction in a Mouse Ischemia-Reperfusion Model. | Iran J Biotechnol | 2026 | https://conductscience.org/library/papers/42145974 | PubMed |
1 to 10 of 61
See all 61 cited byGenes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP13 | 4,322 | PubTator's text mining | https://conductscience.org/library/genes/4322 | NCBI Gene |
| MMP7 | 4,316 | PubTator's text mining | https://conductscience.org/library/genes/4316 | NCBI Gene |
| MMP9 | 4,318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| PTGS2 | 5,743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
| TNFRSF11B | 4,982 | PubTator's text mining | https://conductscience.org/library/genes/4982 | NCBI Gene |
| TNFSF11 | 8,600 | PubTator's text mining | https://conductscience.org/library/genes/8600 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35902802
GET https://conductscience.org/api/papers/v1/35902802/references?page=2